Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2018

01-09-2018 | Letter to the editors

The phenotype of adult versus pediatric patients with inborn errors of metabolism

Authors: Jean-Marie Saudubray, Fanny Mochel

Published in: Journal of Inherited Metabolic Disease | Issue 5/2018

Login to get access

Abstract

Until recently, inborn errors of metabolism (IEM) were considered a pediatric specialty, as emphasized by the term “inborn,” and the concept of adult onset IEM has only very recently reached the adult medical community. Still, an increasing number of adult onset IEM have now been recognized, as new metabolomics and molecular diagnostic techniques have become available. Here, we discuss possible mechanisms underlying phenotypic variability in adult versus children with IEM. Specifically, phenotypic severity and age of onset are expected to be modulated by differences in residual protein activity possibly driven by various genetic factors. Phenotypic variability may also occur in the context of similar protein expression, which suggests the intervention of environmental, ontogenic, and aging factors.
Literature
go back to reference Adanyeguh IM, Rinaldi D, Henry PG et al (2015) Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology 84:490–495CrossRefPubMedPubMedCentral Adanyeguh IM, Rinaldi D, Henry PG et al (2015) Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology 84:490–495CrossRefPubMedPubMedCentral
go back to reference Cleary MA, Dorland L, de Koning TJ et al (2005) Ornithine aminotransferase deficiency: diagnostic difficulties in neonatal presentation. J Inherit Metab Dis 28:673–679CrossRefPubMed Cleary MA, Dorland L, de Koning TJ et al (2005) Ornithine aminotransferase deficiency: diagnostic difficulties in neonatal presentation. J Inherit Metab Dis 28:673–679CrossRefPubMed
go back to reference Degos B, Nadjar Y, Amador M del M et al (2016) Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood. Orphanet J Rare Dis 11:41–44CrossRefPubMedPubMedCentral Degos B, Nadjar Y, Amador M del M et al (2016) Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood. Orphanet J Rare Dis 11:41–44CrossRefPubMedPubMedCentral
go back to reference Dölle C, Flønes I, Nido GS et al (2016) Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. Nat Commun 7:13548–13558CrossRefPubMedPubMedCentral Dölle C, Flønes I, Nido GS et al (2016) Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. Nat Commun 7:13548–13558CrossRefPubMedPubMedCentral
go back to reference Fassier T, Guffon N, Acquaviva C, D'Amato T, Durand DV, Domenech P (2011) Misdiagnosed postpartum psychosis revealing a late-onset urea cycle disorder. Am J Psychiatry 168:576–580CrossRefPubMed Fassier T, Guffon N, Acquaviva C, D'Amato T, Durand DV, Domenech P (2011) Misdiagnosed postpartum psychosis revealing a late-onset urea cycle disorder. Am J Psychiatry 168:576–580CrossRefPubMed
go back to reference Frézal J, Amédée-Manesme O, Mitchell G et al (1985) Maple syrup urine disease: two different forms within a single family. Hum Genet 71:89–91CrossRefPubMed Frézal J, Amédée-Manesme O, Mitchell G et al (1985) Maple syrup urine disease: two different forms within a single family. Hum Genet 71:89–91CrossRefPubMed
go back to reference Garcia-Cazorla A, Saudubray JM (2018) Cellular neurometabolism: a tentative to connect cell biology and metabolism in neurology. J Inherit Metab Dis, in revision Garcia-Cazorla A, Saudubray JM (2018) Cellular neurometabolism: a tentative to connect cell biology and metabolism in neurology. J Inherit Metab Dis, in revision
go back to reference Giorgi M, Morrone A, Donati MA et al (2000) Lymphocyte mRNA analysis of the ornithine transcarbamylase gene in Italian OTCD male patients and manifesting carriers: identification of novel mutations. Hum Mutat 15:380–381CrossRefPubMed Giorgi M, Morrone A, Donati MA et al (2000) Lymphocyte mRNA analysis of the ornithine transcarbamylase gene in Italian OTCD male patients and manifesting carriers: identification of novel mutations. Hum Mutat 15:380–381CrossRefPubMed
go back to reference Giron C, Roze E, Degos B, et al (2018) Adult-onset generalized dystonia as the main manifestation of MEGDEL syndrome. Tremor Other Hyperkinet Mov (N Y) In press Giron C, Roze E, Degos B, et al (2018) Adult-onset generalized dystonia as the main manifestation of MEGDEL syndrome. Tremor Other Hyperkinet Mov (N Y) In press
go back to reference Gras D, Roze E, Caillet S et al (2014) GLUT1 deficiency syndrome: an update. Rev Neurol (Paris) 170:91–99CrossRef Gras D, Roze E, Caillet S et al (2014) GLUT1 deficiency syndrome: an update. Rev Neurol (Paris) 170:91–99CrossRef
go back to reference Kolker S, Garbade SF, Greenberg CR et al (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847CrossRefPubMed Kolker S, Garbade SF, Greenberg CR et al (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847CrossRefPubMed
go back to reference Lodato MA, Rodin RE, Bohrson CL et al (2018) Aging and neurodegeneration are associated with increased mutations in single human neurons. Science 359:555–559CrossRefPubMed Lodato MA, Rodin RE, Bohrson CL et al (2018) Aging and neurodegeneration are associated with increased mutations in single human neurons. Science 359:555–559CrossRefPubMed
go back to reference Maas RR, Iwanicka-Pronicka K, Kalkan Ucar S et al (2017) Progressive deafness-dystonia due to SERAC1 mutations: a study of 67 cases. Ann Neurol 82:1004–1015CrossRefPubMedPubMedCentral Maas RR, Iwanicka-Pronicka K, Kalkan Ucar S et al (2017) Progressive deafness-dystonia due to SERAC1 mutations: a study of 67 cases. Ann Neurol 82:1004–1015CrossRefPubMedPubMedCentral
go back to reference Marelli C, Lamari F, Rainteau D et al (2018) Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5. Brain 141:72–84CrossRefPubMed Marelli C, Lamari F, Rainteau D et al (2018) Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5. Brain 141:72–84CrossRefPubMed
go back to reference Mazzulli JR, Xu YH, Sun Y et al (2011) Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146:37–52CrossRefPubMedPubMedCentral Mazzulli JR, Xu YH, Sun Y et al (2011) Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146:37–52CrossRefPubMedPubMedCentral
go back to reference Mwinyi J, Boström A, Fehrer I et al (2017) Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus. PLoS One 12:e0175776CrossRefPubMedPubMedCentral Mwinyi J, Boström A, Fehrer I et al (2017) Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus. PLoS One 12:e0175776CrossRefPubMedPubMedCentral
go back to reference Mira V, Boles RG (2012) Liver failure with coagulopathy, hyperammonemia and cyclic vomiting in a toddler revealed to have combined heterozygosity for genes involved with ornithine transcarbamylase deficiency and Wilson disease. JIMD Rep 3:1–3PubMed Mira V, Boles RG (2012) Liver failure with coagulopathy, hyperammonemia and cyclic vomiting in a toddler revealed to have combined heterozygosity for genes involved with ornithine transcarbamylase deficiency and Wilson disease. JIMD Rep 3:1–3PubMed
go back to reference Nugent S, Tremblay S, Chen KW et al (2014) Brain glucose and acetoacetate metabolism: a comparison of young and older adults. Neurobiol Aging 35:1386–1395CrossRefPubMed Nugent S, Tremblay S, Chen KW et al (2014) Brain glucose and acetoacetate metabolism: a comparison of young and older adults. Neurobiol Aging 35:1386–1395CrossRefPubMed
go back to reference Orosz F, Olah J, Ovadi J (2009) Triosephosphate isomerase deficiency: new insights into an enigmatic disease. Biochim Biophys Acta 1792:1168–1174CrossRefPubMed Orosz F, Olah J, Ovadi J (2009) Triosephosphate isomerase deficiency: new insights into an enigmatic disease. Biochim Biophys Acta 1792:1168–1174CrossRefPubMed
go back to reference Patterson MC, Mengel E, Wijburg FA et al (2013) Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis 8:12–21CrossRefPubMedPubMedCentral Patterson MC, Mengel E, Wijburg FA et al (2013) Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis 8:12–21CrossRefPubMedPubMedCentral
go back to reference Ramaekers VT, Suormala TM, Brab MR, Duran M, Heimann G, Baumgartner ER (1992) A biotinidase Km variant causing late onset bilateral optic neuropathy. Arch Dis Child 67:115–119CrossRefPubMedPubMedCentral Ramaekers VT, Suormala TM, Brab MR, Duran M, Heimann G, Baumgartner ER (1992) A biotinidase Km variant causing late onset bilateral optic neuropathy. Arch Dis Child 67:115–119CrossRefPubMedPubMedCentral
go back to reference Ridout CK, Brown RM, Walter JH, Brown GK (2008) Somatic mosaicism for a PDHA1 mutation in a female with pyruvate dehydrogenase deficiency. Hum Genet 124:187–193CrossRefPubMed Ridout CK, Brown RM, Walter JH, Brown GK (2008) Somatic mosaicism for a PDHA1 mutation in a female with pyruvate dehydrogenase deficiency. Hum Genet 124:187–193CrossRefPubMed
go back to reference Saudubray JM, Garcia Cazorla A (2016) Clinical approach to inborn errors of metabolism in pediatrics. In: Saudubray JM, Baumgartner M, Walter J (eds) Inborn metabolic diseases 6th edition. Springer Heidelberg, vol 629, pp 2–70CrossRef Saudubray JM, Garcia Cazorla A (2016) Clinical approach to inborn errors of metabolism in pediatrics. In: Saudubray JM, Baumgartner M, Walter J (eds) Inborn metabolic diseases 6th edition. Springer Heidelberg, vol 629, pp 2–70CrossRef
go back to reference Sedel F, Challe G, Mayer JM et al (2008) Thiamine responsive pyruvate dehydrogenase deficiency in an adult with peripheral neuropathy and optic neuropathy. J Neurol Neurosurg Psychiatry 79:846–847CrossRefPubMed Sedel F, Challe G, Mayer JM et al (2008) Thiamine responsive pyruvate dehydrogenase deficiency in an adult with peripheral neuropathy and optic neuropathy. J Neurol Neurosurg Psychiatry 79:846–847CrossRefPubMed
go back to reference Simonaro CM, Park JH, Eliyahu E, Shtraizent N, McGovern MM, Schuchman EH (2006) Imprinting at the SMPD1 locus: implications for acid sphingomyelinase-deficient Niemann-Pick disease. Am J Hum Genet 78:865–870CrossRefPubMedPubMedCentral Simonaro CM, Park JH, Eliyahu E, Shtraizent N, McGovern MM, Schuchman EH (2006) Imprinting at the SMPD1 locus: implications for acid sphingomyelinase-deficient Niemann-Pick disease. Am J Hum Genet 78:865–870CrossRefPubMedPubMedCentral
go back to reference Takahashi S, Matsufuji M, Yonee C, Tsuru H, Sano N, Oguni H (2017) Somatic mosaicism for a SLC2A1 mutation: implications for genetic counseling for GLUT1 deficiency syndrome. Clin Genet 91:932–933CrossRefPubMed Takahashi S, Matsufuji M, Yonee C, Tsuru H, Sano N, Oguni H (2017) Somatic mosaicism for a SLC2A1 mutation: implications for genetic counseling for GLUT1 deficiency syndrome. Clin Genet 91:932–933CrossRefPubMed
go back to reference van Leeuwen J, Pons C, Mellor JC et al (2016) Exploring genetic suppression interactions on a global scale. Science 354:599 van Leeuwen J, Pons C, Mellor JC et al (2016) Exploring genetic suppression interactions on a global scale. Science 354:599
go back to reference Verma M, Charles RCM, Chakrapani B et al (2017) PRMT7 interacts with ASS1 and citrullinemia mutations disrupt the interaction. J Mol Biol 429:2278–2289CrossRefPubMed Verma M, Charles RCM, Chakrapani B et al (2017) PRMT7 interacts with ASS1 and citrullinemia mutations disrupt the interaction. J Mol Biol 429:2278–2289CrossRefPubMed
go back to reference Vockley J, Rinaldo P, Bennett MJ, Matern D, Vladutiu GD (2000) Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol Genet Metab 71:10–18CrossRefPubMed Vockley J, Rinaldo P, Bennett MJ, Matern D, Vladutiu GD (2000) Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol Genet Metab 71:10–18CrossRefPubMed
go back to reference Weiss N, Mochel F, Rudler M et al (2018) Peak hyperammonemia and atypical acute liver failure: the eruption of an urea cycle disorder during hyperemesis gravidarum. J Hepatol 68:185–192CrossRef Weiss N, Mochel F, Rudler M et al (2018) Peak hyperammonemia and atypical acute liver failure: the eruption of an urea cycle disorder during hyperemesis gravidarum. J Hepatol 68:185–192CrossRef
Metadata
Title
The phenotype of adult versus pediatric patients with inborn errors of metabolism
Authors
Jean-Marie Saudubray
Fanny Mochel
Publication date
01-09-2018
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2018
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-018-0209-9

Other articles of this Issue 5/2018

Journal of Inherited Metabolic Disease 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine